Instem Group
- Home
- Companies
- Instem Group
- Software
- NOTOCORD-hem - Software Platform for ...
NOTOCORD-hem - Software Platform for Acquisition, Display and Analysis
FromInstem Group
NOTOCORD-hem™, developed by NOTOCORD, and now part the Instem solutions portfolio is the leading software platform for the acquisition, display and analysis of physiological signals, with a focus on the areas of Cardiovascular, Respiratory and Nervous System Research. NOTOCORD-hem is used by pharmaceutical companies, contract research laboratories, hospitals and academic research centers around the world.
Most popular related searches
implant device
nervous system
hospital research
implant
pharmaceutical research
cardiovascular
hospital laboratory
physiological analysis
cardiovascular system
- Over 160 modules for a customized analysis
- In vivo, In vitro and Ex vivo
- Large range of hardware compatibility from analogue to implantable devices
- Simultaneous acquisition from different sources and systems
- Flexible user interfaces offering easy configuration and displays
- Ultra-fast access to data regardless of experiment file size
- Unique Microsoft Excel® Add-in for individualized reporting
- Compliance with GLP & 21 CFR Part 11
NOTOCORD-hem can be installed in a GLP environment, adding access control and audit trail functionalities, restricted access to authorized individuals and use of electronic signatures.
NOTOCORD-hem is an open software platform compatible with multiple acquisition devices, including implants, and other software.